Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Haim R. Branisteanu who wrote (171767)	5/15/2021 4:10:59 AM
From: TobagoJack	2 Recommendations Recommended By Haim R. Branisteanu marcher Respond to of 220490

In my experience traditional medicine cures, and there must be traditional medicine 'tradition' all across the planet. Perhaps, as in maybe, TCM is one of the most developed ways & means, but there must be others, even if specific to local conditions of whenever that are efficacious. I do not expect Pfizer and such to champion such, because 'there is no money in it' xinhuanet.com TCM can help halve COVID-19 death rate: reportBEIJING, May 10 (Xinhua) -- A recent study has shown that Qingfei Paidu soup, a traditional Chinese medicine (TCM) widely used to treat COVID-19, can help reduce the rate of death among hospitalized patients by half, China Daily reported Monday. The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College, examined more than 8,900 hospitalized COVID-19 cases in Hubei Province, the hardest-hit region during the epidemic, from January to May last year. Nearly 30 percent of the patients had taken Qingfei Paidu as part of their therapies. Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent, said the report. The study concluded that the use of Qingfei Paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries. The newspaper cited Li Jing, head of the research team, as saying that based on the national diagnosis and treatment guidelines for COVID-19, Qingfei Paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases. Qingfei Paidu is a concoction made of dozens of TCM herbs and roots such as ephedra, licorice root and bitter almond. The study is by far the largest clinical research on Qingfei Paidu and its findings have provided strong evidence proving its marked efficacy in saving the lives of COVID-19 patients, according to the National Administration of Traditional Chinese Medicine. Enditem